YCBD

cbdMD, Inc. [YCBD] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

YCBD Stock Summary

Top 10 Correlated Stocks

YCBD


In the News

04:05 29 Mar 2024 YCBD

cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2024 Results

Charlotte, North Carolina--(Newsfile Corp. - February 8, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Tuesday, February 13, 2024, to discuss the company's December 31, 2023 first quarter of fiscal 2024 financial results and business progress.

12:47 29 Mar 2024 YCBD

cbdMD, Inc. to Host Conference Call to Discuss September 30, 2023 Fourth Quarter and Fiscal Year 2023 Results

Charlotte, North Carolina--(Newsfile Corp. - December 20, 2023) -  cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Friday December 22, 2023, to discuss the company's September 30, 2023 fourth quarter of fiscal 2023 and full year of fiscal 2023 financial results and business progress.

10:00 29 Mar 2024 YCBD

cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2023 Results

Charlotte, North Carolina--(Newsfile Corp. - August 7, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:30 p.m., Eastern Time, on Thursday August 10, 2023, to discuss the company's June 30, 2023 third quarter of fiscal 2023 financial results and business progress.

07:30 29 Mar 2024 YCBD

cbdMD, Inc. (YCBD) Q2 2023 Earnings Call Transcript

cbdMD, Inc. (NYSE:YCBD ) Q2 2023 Earnings Conference Call May 15, 2023 4:15 PM ET Company Participants Brad Whitford - VP of Finance Ronan Kennedy - Interim Chief Executive Officer and Chief Financial Officer Sibyl Swift - Chief Science Officer & VP Regulatory Affairs Conference Call Participants Anthony Vendetti - Maxim Group Operator Good afternoon. Welcome to cbdMD's, Inc. March 31, 2023, Second Quarter of Fiscal '23 Earnings Call and Update.

02:59 29 Mar 2024 YCBD

cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2023 Results

Charlotte, North Carolina--(Newsfile Corp. - May 10, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:15 p.m., Eastern Time, on Monday, May 15, 2023, to discuss the company's March 31, 2023 second quarter of fiscal 2023 financial results and business progress.

07:37 29 Mar 2024 YCBD

cbdMD, Inc. (YCBD) Q4 2022 Earnings Call Transcript

cbdMD, Inc. (NYSE:YCBD ) Q4 2022 Earnings Conference Call February 13, 2022 4:15 PM ET Company Participants Brad Whitford - VP of Finance Ronan Kennedy - CFO and COO Kevin MacDermott - President Conference Call Participants Operator Good afternoon. Welcome to cbdMD Inc.'s December 31, 2022 First Quarter of Fiscal 2023 Earnings Call and Update.

02:02 29 Mar 2024 YCBD

cbdMD, Inc. (YCBD) Q4 2022 Earnings Call Transcript

cbdMD, Inc. (NYSE:YCBD ) Q4 2022 Earnings Conference Call December 15, 2022 4:15 PM ET Company Participants Ronan Kennedy - CFO and COO Kevin MacDermott - President Sibyl Swift - VP of Scientific and Regulatory Affairs Conference Call Participants Operator Good afternoon. Welcome to cbdMD Inc.'s September 30 Fourth Quarter and Fiscal 2022 Earnings Call and Update.

05:06 29 Mar 2024 YCBD

cbdMD, Inc. to Host Conference Call to Discuss Fourth Quarter and Fiscal 2022 Results

Charlotte, North Carolina--(Newsfile Corp. - December 14, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:15 p.m., Eastern Time, on Thursday, December 15, 2022, to discuss the company's September 30, 2022 fourth quarter and fiscal 2022 financial results and business progress.CONFERENCE CALL DETAILSThursday, December 15, 2022, 4:15 p.m. Eastern Time

04:14 29 Mar 2024 YCBD

cbdMD, Inc. (YCBD) Q3 2022 Results - Earnings Call Transcript

cbdMD, Inc. (NYSE:YCBD ) Q3 2022 Results Conference Call August 11, 2022 4:30 PM ET Company Participants Ronan Kennedy - CFO and COO Scott Stephen - Chairman Kevin MacDermott - President Dr. Sibyl Swift - Vice President of Scientific and Regulatory Affairs Conference Call Participants Jeff Porter - Porter Capital Management Operator Good afternoon. Welcome to the cbdMD Inc.'s June 30, 2022 Third Quarter of Fiscal 2022 Earnings Call and Update.

07:22 29 Mar 2024 YCBD

cbdMD, Inc. (YCBD) CEO Marty Sumichrast on Q2 2022 Results - Earnings Call Transcript

cbdMD, Inc. (NYSE:YCBD ) Q2 2022 Earnings Conference Call May 13, 2022 4:30 PM ET Company Participants Ronan Kennedy - CFO and COO Marty Sumichrast - Chairman and Co-CEO Sibyl Swift - VP, Scientific & Regulatory Affairs Conference Call Participants Operator Good afternoon, and welcome to cbdMD, Inc.'s March 31, 2022, Second Quarter of Fiscal 2022 Earnings Call and Update. This afternoon, the company issued a press release that provided an overview of its second quarter of fiscal year 2022 results, which followed the filing of its quarterly report on Form 10-Q.

YCBD Financial details

Company Rating
Neutral
Market Cap
2.77M
Income
41.92M
Revenue
23.45M
Book val./share
2.38
Cash/share
0.51
Dividend
-
Dividend %
-
Employees
52
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
0.52
Forward P/E
-1.94
PEG
-0.04
P/S
0.11
P/B
2.17
P/C
1.82
P/FCF
-0.6
Quick Ratio
0.65
Current Ratio
1.73
Debt / Equity
0.48
LT Debt / Equity
0.29
-
-
EPS (TTM)
15.5
EPS next Y
-0.48
EPS next Q
-0.75
EPS this Y
-79.68%
EPS next Y
-103.1%
EPS next 5Y
-103.1%
EPS last 5Y
-37%
Revenue last 5Y
0.42%
Revenue Q/Q
-5.87%
EPS Q/Q
-95.67%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
4262.6%
Inst Trans
0.18%
ROA
234%
ROE
174%
ROC
-1.95%
Gross Margin
62%
Oper. Margin
-93%
Profit Margin
157%
Payout
10%
Shs Outstand
3.05M
Shs Float
2.37M
-
-
-
-
Target Price
-
52W Range
0.56-9.45
52W High
-
52W Low
-
RSI
64
Rel Volume
0.27
Avg Volume
790.75K
Volume
210.5K
Perf Week
24.08%
Perf Month
34.78%
Perf Quarter
-4.12%
Perf Half Y
-9.71%
-
-
-
-
Beta
2.106
-
-
Volatility
0.05%, 0.11%
Prev Close
0%
Price
0.93
Change
-10.58%

YCBD Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-09-30

Metric History 2019-09-302020-09-302021-09-302022-09-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
59.542.736.4326.6711.94
Net income per share
-114.2912.85-19.16-55.8-11.34
Operating cash flow per share
-38.69-10.87-11.54-11.27-2.13
Free cash flow per share
-41.83-12.22-13.46-11.79-2.27
Cash per share
13.8115.422.485.810.89
Book value per share
94.680.7284.4823.674.47
Tangible book value per share
-97.362.9319.1310.242.87
Share holders equity per share
94.680.7284.4823.674.47
Interest debt per share
2.28.8553.681.82
Market cap
70.83M88.28M114.27M13.45M2.08M
Enterprise value
66.14M82.14M93.93M11.6M3.97M
P/E ratio
-1.567.01-4.88-0.18-0.09
Price to sales ratio
2.992.112.570.380.09
POCF ratio
-4.61-8.28-8.11-0.9-0.48
PFCF ratio
-4.26-7.37-6.95-0.86-0.45
P/B Ratio
1.881.111.110.430.23
PTB ratio
1.881.111.110.430.23
EV to sales
2.81.962.110.330.16
Enterprise value over EBITDA
3.4-1.8-7.40.30.54
EV to operating cash flow
-4.3-7.7-6.66-0.77-0.92
EV to free cash flow
-3.98-6.85-5.72-0.74-0.86
Earnings yield
-0.640.14-0.2-5.51-11.01
Free cash flow yield
-0.23-0.14-0.14-1.16-2.21
Debt to equity
0.020.110.060.150.41
Debt to assets
0.010.080.050.120.23
Net debt to EBITDA
-0.240.131.6-0.050.25
Current ratio
4.243.085.283.031.73
Interest coverage
00-678.052.2K0
Income quality
0.3-0.850.60.210.19
Dividend Yield
000.020.31.76
Payout ratio
00.03-0.11-0.05-0.16
Sales general and administrative to revenue
00.550.490.450.4
Research and developement to revenue
00.010.030.020.01
Intangibles to total assets
0.810.690.640.440.2
Capex to operating cash flow
0.080.120.170.050.07
Capex to revenue
-0.05-0.03-0.05-0.02-0.01
Capex to depreciation
-4.31-1.83-1.04-0.23-0.1
Stock based compensation to revenue
0.110.050.070.030.01
Graham number
493.23152.76190.86172.3833.76
ROIC
0.47-0.21-0.160.92-2.19
Return on tangible assets
-2.490.36-0.52-3.23-1.77
Graham Net
-118.93-13.57.421.18-1.2
Working capital
12.03M16.02M29.59M10.73M3.4M
Tangible asset value
-38.7M2.88M23.35M13.59M5.81M
Net current asset value
-41.17M-7.95M14.76M6.64M906.04K
Invested capital
0.020.110.060.150.41
Average receivables
3.44M2.01M1.24M1.29M1.33M
Average payables
1.75M2.94M2.91M2.51M1.97M
Average inventory
2.21M4.45M4.81M4.64M4.15M
Days sales outstanding
41.1411.849.2314.9418.38
Days payables outstanding
120.767.0675.0156.8975.81
Days of inventory on hand
171.84108.3126.46118.88161.19
Receivables turnover
8.8730.8339.5624.4319.86
Payables turnover
3.025.444.876.424.81
Inventory turnover
2.123.372.893.072.26
ROE
-1.210.16-0.23-2.36-2.54
Capex per share
-3.14-1.35-1.92-0.52-0.15

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q1

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
4.542.626.082.821.82
Net income per share
-3.725.45-1.76-7.85-0.34
Operating cash flow per share
-1.54-0.73-0.24-0.13-0.04
Free cash flow per share
-1.67-0.69-0.34-0.19-0.1
Cash per share
3.250.722.830.890.51
Book value per share
19.8210.8425.564.472.38
Tangible book value per share
6.743.578.672.871.35
Share holders equity per share
19.8210.8425.564.472.38
Interest debt per share
3.441.83.961.811.14
Market cap
13.71M20.89M1.41M2.08M3.08M
Enterprise value
14.94M23.46M2.55M3.97M4.94M
P/E ratio
-0.690.09-0.2-0.03-0.77
Price to sales ratio
2.253.350.230.360.57
POCF ratio
-6.64-12.05-5.86-7.91-27.4
PFCF ratio
-6.11-12.81-4.11-5.43-10.37
P/B Ratio
0.520.810.050.230.44
PTB ratio
0.520.810.050.230.44
EV to sales
2.453.760.420.690.92
Enterprise value over EBITDA
-4.33-28.42-2.420.31-11.66
EV to operating cash flow
-7.24-13.53-10.6-15.06-43.98
EV to free cash flow
-6.66-14.38-7.43-10.34-16.64
Earnings yield
-0.362.9-1.26-7.62-0.32
Free cash flow yield
-0.16-0.08-0.24-0.18-0.1
Debt to equity
0.170.170.150.410.48
Debt to assets
0.130.130.120.230.22
Net debt to EBITDA
-0.36-3.11-1.080.15-4.4
Current ratio
2.082.172.31.731.23
Interest coverage
-138.95-719.75-1.46K470.96-2.39K
Income quality
0.521.30.140.020.11
Dividend Yield
0.070.050.710.320
Payout ratio
-0.20.02-0.57-0.040
Sales general and administrative to revenue
0.630.420.370.170.35
Research and developement to revenue
0.010.01000
Intangibles to total assets
0.490.510.520.20.2
Capex to operating cash flow
0.09-0.060.430.461.64
Capex to revenue
-0.030.02-0.02-0.02-0.03
Capex to depreciation
-0.270.18-0.13-0.130.32
Stock based compensation to revenue
0.020.010.010.020.33
Graham number
40.678.7731.8128.084.24
ROIC
-0.141.85-30.63-1.72-80.44
Return on tangible assets
-0.273.69-0.11-1.22-0.08
Graham Net
-1.32-1.28-1.41-1.2-1.3
Working capital
5.98M5.47M5.71M3.4M1.39M
Tangible asset value
9.03M8.51M8.73M5.81M3.99M
Net current asset value
2.39M2.25M2.85M906.04K-692.46K
Invested capital
0.170.170.150.410.48
Average receivables
1.17M1.03M1.14M1.16M1.16M
Average payables
1.86M1.51M1.37M1.66M1.74M
Average inventory
4.47M4.61M4.4M4.16M3.9M
Days sales outstanding
13.2916.7516.3519.1718.45
Days payables outstanding
60.454.1255.8879.3667.09
Days of inventory on hand
167.69183.35169.28168.73160.28
Receivables turnover
6.775.375.54.74.88
Payables turnover
1.491.661.611.131.34
Inventory turnover
0.540.490.530.530.56
ROE
-0.192.35-0.07-1.76-0.14
Capex per share
-0.130.04-0.1-0.06-0.06

YCBD Frequently Asked Questions

What is cbdMD, Inc. stock symbol ?

cbdMD, Inc. is a US stock , located in Charlotte of Nc and trading under the symbol YCBD

What is cbdMD, Inc. stock quote today ?

cbdMD, Inc. stock price is $0.93 today.

Is cbdMD, Inc. stock public?

Yes, cbdMD, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Top Correlated Stocks
Similar Market Cap